Decellularization Explained: How Biological Tissue Becomes an ECM Scaffold

What Is Decellularization?#

Decellularization is the process of removing cells and cellular components from tissues or organs while attempting to preserve the extracellular matrix.

The resulting material is commonly referred to as decellularized extracellular matrix, abbreviated dECM.

When dermis is used as the starting tissue, the resulting scaffold may be described as an Acellular Dermal Matrix, or ADM.

The reason for removing cellular material is largely biological.

Cells contain DNA, membrane components, intracellular proteins and antigens that can contribute to host immune responses.

At the same time, the extracellular matrix contains structural proteins and other molecules that may provide useful architecture for tissue interaction.

The challenge is separating these two systems without excessively damaging the matrix.

Why Decellularization Is Difficult#

Imagine trying to remove every person and every item from a complex building while leaving the architecture undamaged.

More aggressive removal techniques may empty the building more completely—but they may also damage the walls.

Gentler methods may preserve the structure but leave unwanted material behind.

Decellularization has the same fundamental trade-off.

An insufficient process may leave excessive cellular remnants.

An overly aggressive process may disrupt collagen, elastin, glycosaminoglycans, basement-membrane components or the three-dimensional microarchitecture.

Therefore, there is no universal decellularization protocol appropriate for every tissue.

Dense dermis, thin membrane, tendon and whole organs have very different structures.

The protocol must be adapted to the biological starting material and intended final application.

The Three Major Categories of Decellularization Methods#

Most decellularization strategies use combinations of physical, chemical and biological methods.

Physical methods#

Physical approaches can include agitation, pressure changes, temperature-based techniques and mechanical disruption.

These methods can assist in cell lysis or improve penetration of other processing agents.

The disadvantage is that excessive physical force may disrupt extracellular architecture.

Chemical methods#

Chemical decellularization can involve detergents, acids, bases or other solutions capable of disrupting cell membranes and removing cellular material.

Detergents are particularly common.

Different detergents interact with tissues differently.

Some are highly effective at cellular removal but may also damage proteins or remove glycosaminoglycans.

Others can be gentler but less effective in dense tissues.

Residual chemicals must also be adequately removed after processing.

Biological and enzymatic methods#

Enzymes can be used to break down cellular proteins or nucleic acids.

Nucleases, for example, can assist in degrading residual DNA and RNA.

Enzymatic processing can be useful, but inappropriate concentration or exposure time may affect extracellular components.

Modern protocols therefore commonly combine multiple approaches rather than relying on one agent alone.

How Do Scientists Determine Whether a Tissue Is Decellularized?#

One of the most influential papers in this field was the 2011 review by Peter Crapo, Thomas Gilbert and Stephen Badylak.

The authors proposed three minimal criteria that subsequently became widely used as reference points for decellularization.

• The proposed criteria were:
• less than 50 nanograms of double-stranded DNA per milligram of dry extracellular matrix
• remaining DNA fragments shorter than 200 base pairs

and no visible nuclear material in tissue sections stained with 4′,6-diamidino-2-phenylindole (DAPI) or hematoxylin and eosin (H&E).

These criteria were highly influential because they provided measurable benchmarks in a field that previously lacked consistent quantitative definitions.

However, they should not be interpreted as a complete quality specification for every modern dECM product.

Passing DNA criteria tells us something important about cellular removal.

It does not tell us everything about the preserved matrix.

DNA Removal Is Only Half of the Question#

Consider two hypothetical scaffolds.

Both contain less than 50 ng of residual double-stranded DNA per milligram of dry material.

The first retains an organized collagen architecture and appropriate mechanical properties.

The second has been severely damaged during processing.

Both may satisfy a DNA threshold.

They are not necessarily equivalent biomaterials.

This illustrates why decellularization quality has two major dimensions:

How effectively were unwanted cellular components removed?

and

What useful matrix characteristics survived the process?

A complete material characterization therefore requires more than a DNA measurement.

Histology and Microscopy#

Histological techniques allow researchers to examine the organization of the processed tissue.

Hematoxylin and eosin staining can help evaluate visible cellular or nuclear remnants and general architecture.

DAPI staining specifically highlights nuclear material.

Other stains may be used to examine matrix components.

Scanning electron microscopy or other imaging methods can provide additional information about surface and microstructural architecture.

These techniques help answer a question that biochemical measurements alone cannot:

Does the scaffold still resemble an organized extracellular structure?

Biochemical Characterization#

The extracellular matrix is composed of many molecules.

Depending on the intended material, researchers may measure collagen, elastin, glycosaminoglycans or selected matrix-associated proteins.

More advanced studies may use proteomics to examine a much broader range of retained proteins.

Interpretation requires caution.

The presence of a molecule does not necessarily prove that it retains its original spatial organization or biological activity.

Nevertheless, biochemical analysis provides important information about how processing changes the starting tissue.

Mechanical Testing#

Processing can change the strength, stiffness and extensibility of a scaffold.

These characteristics are particularly important for materials used in mechanically active environments.

Dermal tissue, for example, must tolerate deformation.

A process that removes cells effectively but dramatically damages collagen architecture may change mechanical behaviour.

Mechanical characterization can include tensile testing, elastic modulus and other measurements selected according to the intended application.

Again, no single test defines quality.

The test should reflect the function expected from the final material.

Why Processing Protocols Cannot Be Compared by One Variable#

It is tempting to compare two protocols by asking which removes more DNA.

That comparison can be misleading.

A decellularization process is a system.

Detergent identity, concentration, temperature, agitation, exposure time, enzyme treatment, number of washes and tissue thickness all interact.

Changing one parameter can influence several outcomes simultaneously.

An aggressive detergent may improve cellular removal while reducing certain extracellular components.

Long washing may remove detergent residues more effectively but also prolong processing.

Enzyme treatment may reduce nucleic-acid burden but affect matrix proteins if poorly controlled.

The optimal protocol therefore involves a multi-variable compromise.

Decellularization and Immunogenicity#

One purpose of decellularization is to reduce components that could contribute to unwanted immune responses.

However, the term non-immunogenic should be used carefully.

Biological host responses are complex.

Residual cells and antigens matter, but so do tissue source, matrix damage, degradation products, contamination and patient-specific biology.

No processing method should be assumed to eliminate every possible immunological interaction simply because the scaffold is described as acellular.

A more defensible scientific statement is that decellularization is intended to reduce cellular and potentially immunogenic components while retaining useful extracellular structure.

The effectiveness of that process should then be demonstrated through characterization.

What Happens After Decellularization?#

Producing a clinically useful scaffold involves additional steps.

Depending on the product, these may include shaping, thickness control, washing, preservation, freeze-drying, crosslinking, packaging, sterilization or other terminal processing.

Each step can influence the final material.

For example, crosslinking may increase resistance to degradation but can alter remodeling.

Sterilization methods may affect proteins or mechanical properties.

Freeze-drying can change physical structure depending on formulation and process conditions.

This means the final scaffold should be characterized after relevant manufacturing steps, rather than assuming that measurements performed on an intermediate material describe the finished product.

Why This Matters for Acellular Dermal Matrix#

Acellular Dermal Matrix begins with a biologically complex tissue.

Its final performance therefore depends heavily on processing.

Two products can both truthfully be described as “ADM” while having substantially different characteristics.

For clinicians and researchers, useful questions include:

What tissue was used?

How was it decellularized?

How was decellularization verified?

What matrix architecture remains?

What biochemical components were measured?

What are its mechanical properties?

Was the material crosslinked?

How was it preserved?

How was it sterilized or otherwise terminally processed?

What product-specific clinical evidence exists?

These questions provide far more information than the label “biologic scaffold.”

The Future of Decellularization#

A 2026 review of dECM research describes a movement toward increasingly tissue-specific and integrated processing approaches.

Emerging research includes supercritical carbon dioxide processing, more automated manufacturing, advanced monitoring and combinations of techniques designed to improve preservation while achieving consistent cellular removal.

Researchers are also developing dECM for applications very different from traditional sheet scaffolds.

Processed matrix can be milled into particles, converted into hydrogels or incorporated into bioinks for three-dimensional bioprinting.

These new forms create additional quality challenges because digestion, solubilization and reformulation can substantially change the original tissue architecture.

Future dECM science will therefore depend increasingly on standardized characterization.

From “Acellular” to Fully Characterized Biomaterial#

The field is gradually moving beyond a simple binary description:

cells present versus cells absent.

• A sophisticated extracellular-matrix biomaterial should instead be described by several dimensions:
• cellular-remnant burden
• matrix composition
• three-dimensional architecture
• mechanical properties
• processing residues
• biological response
• manufacturing consistency

and application-specific clinical evidence.

This framework is more demanding.

It is also more scientifically useful.

Does decellularization remove all DNA?#

Complete removal of every DNA molecule is difficult. The field therefore uses quantitative measurements of residual DNA and fragment size rather than assuming absolute zero.

Does successful decellularization mean the ECM is completely unchanged?#

No. All processing methods can alter extracellular matrix to some degree. The objective is an acceptable balance between cellular removal and preservation of relevant matrix characteristics.

Is every decellularized matrix an ADM?#

No. ADM specifically refers to matrices derived from dermal tissue. dECM can be produced from many different tissues.

Conclusion#

Decellularization is the technology that makes many extracellular-matrix scaffolds possible.

Its scientific objective is not simply to remove cells.

It is to remove cellular material while preserving enough of the appropriate extracellular environment to create a useful biomaterial.

That balance makes processing methodology one of the most important determinants of dECM and ADM characteristics.

• For modern regenerative medicine, the question is therefore no longer just:
• “Is this tissue decellularized?”
• The better question is:
• “What was removed, what was preserved, how was it measured, and what does the finished scaffold actually do?”